Lannett Co Inc (NYSE:LCI) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Friday. According to Zacks, “Lannett, Inc. manufactures and distributes pharmaceutical products sold under generic names and historically has manufactured and distributed pharmaceutical products sold under its trade or brand names. In addition, […]
